Published in Pathology on June 01, 2013
Synchronous colorectal cancer: clinical, pathological and molecular implications. World J Gastroenterol (2014) 1.04
Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF. Front Oncol (2013) 1.02
Future directions for monitoring treatment response in colorectal cancer. J Cancer (2014) 0.96
The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer (2015) 0.94
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer. Invest New Drugs (2014) 0.87
Genetics and epigenetics of sporadic thyroid cancer. Mol Cell Endocrinol (2013) 0.85
Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma. Pathology (2014) 0.85
BRAF Mutation in Hairy Cell Leukemia. Oncol Rev (2014) 0.81
Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers. Int J Clin Exp Pathol (2013) 0.80
Synchronous triple colorectal carcinoma: a case report and review of literature. Int J Clin Exp Pathol (2015) 0.79
Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture. Gut (2016) 0.79
BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells. Oncotarget (2016) 0.78
Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials. PLoS One (2016) 0.77
In silico identification of novel kinase inhibitors by targeting B-Raf(v660e) from natural products database. J Mol Model (2015) 0.77
Novel FAM134B mutations and their clinicopathological significance in colorectal cancer. Hum Genet (2017) 0.76
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. Exp Hematol Oncol (2013) 0.75
Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice. Mol Carcinog (2016) 0.75
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia. Front Pharmacol (2016) 0.75
Germline large genomic alterations on 7q in patients with multiple primary cancers. Sci Rep (2017) 0.75
Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome. Sci Rep (2016) 0.75
An extremely rare case of concurrent BRAF V600E mutation driven hairy cell leukemia and melanoma: case report and review of literature. Autops Case Rep (2017) 0.75
Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck (2009) 1.49
Signet-ring cell carcinoma of colorectum--current perspectives and molecular biology. Int J Colorectal Dis (2010) 1.23
Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant. Hum Pathol (2010) 1.15
Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg (2006) 1.11
Oxidative stress in neurodegeneration and available means of protection. Front Biosci (2008) 1.08
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma. Ann Surg (2008) 0.99
Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology (2008) 0.92
Rabies in Henan province, China, 2010-2012. Emerg Infect Dis (2014) 0.87
GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features. Hum Pathol (2010) 0.84
Irinotecan therapy and molecular targets in colorectal cancer: a systemic review. World J Gastroenterol (2009) 0.84
The important roles of miR-205 in normal physiology, cancers and as a potential therapeutic target. Curr Cancer Drug Targets (2014) 0.83
BRAF inhibitor therapy for melanoma, thyroid and colorectal cancers: development of resistance and future prospects. Curr Cancer Drug Targets (2014) 0.83
Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma. Hum Pathol (2013) 0.82
Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Mol Carcinog (2013) 0.81
MicroRNA-34 family, mechanisms of action in cancer: a review. Curr Cancer Drug Targets (2014) 0.81
Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Hum Pathol (2008) 0.80
The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma. Surgery (2008) 0.79
Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells. Biol Cell (2012) 0.79
Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma. World J Gastroenterol (2013) 0.78
Myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8+CD4+ T cells: evidence from myeloma-bearing mouse model. J Immunol (2011) 0.77
Irinotecan and colorectal cancer: the role of p53, VEGF-C and alpha-B-crystallin expression. Int J Colorectal Dis (2009) 0.76
Altered JS-2 expression in colorectal cancers and its clinical pathological relevance. Mol Oncol (2011) 0.76
Melaleuca alternifolia concentrate inhibits in vitro entry of influenza virus into host cells. Molecules (2013) 0.75
Orofacial viral infections--an update for clinicians. Dent Update (2014) 0.75
Correction: Gold-loaded nanoporous iron oxide nanocubes: a novel dispersible capture agent for tumor-associated autoantibody analysis in serum. Nanoscale (2017) 0.75
A p-menth-1-ene-4,7-diol (EC-1) from Eucalyptus camaldulensis Dhnh. triggers apoptosis and cell cycle changes in Ehrlich ascites carcinoma cells. Phytother Res (2015) 0.75
Spatiotemporal patterns of stable isotopes and hydrochemistry in springs and river flow of the upper Karkheh River Basin, Iran. Isotopes Environ Health Stud (2014) 0.75
Gene amplified in oesophageal cancer 1 (GAEC1) amplification in colorectal cancers and its impact on patient's survival. J Clin Pathol (2013) 0.75
Surgical pathology of patients living in Kiribati. Pathology (2007) 0.75